PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2012.44.2.1272012442127-132A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic CancerJong Gwon Choi, Jae Hong Seo, Sang Cheul Oh, Chul Won Choi, Jun Suk Kimhttp://www.e-crt.org/upload/pdf/crt-44-127.pdf, http://www.e-crt.org/upload/pdf/crt-44-127.pdf
European Journal of Cancer Supplements10.1016/s1359-6349(05)81030-4200532209735 POSTER Randomized comparison of capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (GemOx) in advanced pancreatic cancerhttps://api.elsevier.com/content/article/PII:S1359634905810304?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634905810304?httpAccept=text/plain
European Journal of Cancer Supplements10.1016/s1359-6349(05)82014-220053412PS11 Best of ECCO 13 Phase III randomised comparison of gemcitabine (GEM) versus gemcitabine plus capecitabine (GEM-CAP) in patients with advanced pancreatic cancerhttps://api.elsevier.com/content/article/PII:S1359634905820142?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634905820142?httpAccept=text/plain
Breast Diseases: A Year Book Quarterly10.1016/j.breastdis.2011.10.0142011224413-415Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancerR. Rozner, A.D. Seidmanhttps://api.elsevier.com/content/article/PII:S1043321X1100289X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1043321X1100289X?httpAccept=text/plain
Annals of Oncology10.1093/annonc/mdm4672008192340-347Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancerS. Boeck, T. Hoehler, G. Seipelt, R. Mahlberg, A. Wein, A. Hochhaus, H.-P. Boeck, B. Schmid, E. Kettner, M. Stauch, F. Lordick, Y. Ko, M. Geissler, K. Schoppmeyer, G. Kojouharoff, A. Golf, S. Neugebauer, V. Heinemannhttps://api.elsevier.com/content/article/PII:S0923753419413355?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419413355?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/19/2/340/723939/mdm467.pdf
European Journal of Cancer10.1016/s0959-8049(01)81658-0200137S315-S316Gemcitabine (GEM) and capecitabine (CAP) for advanced pancreatic cancer. A phase I/II trialV. Hess, M. Bomer, R. Morant, A.D. Roth, C. Ludwig, R. Hermanhttps://api.elsevier.com/content/article/PII:S0959804901816580?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0959804901816580?httpAccept=text/plain
Cancers10.3390/cancers1207197520201271975Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine—A Randomized Phase II TrialAlice Markussen, Lars Henrik Jensen, Laura Vittrup Diness, Finn Ole Larsenhttps://www.mdpi.com/2072-6694/12/7/1975/pdf
British Journal of Cancer10.1038/bjc.2011.86201110471071-1078Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancerH J Stemmler, D diGioia, W Freier, H W Tessen, G Gitsch, W Jonat, W Brugger, E Kettner, W Abenhardt, H Tesch, H J Hurtz, S Rösel, O Brudler, V Heinemannhttp://www.nature.com/articles/bjc201186.pdf, http://www.nature.com/articles/bjc201186, http://www.nature.com/articles/bjc201186.pdf
European Journal of Cancer Supplements10.1016/s1359-6349(05)81074-2200532222779 PUBLICATION Phase I trial of capecitabine and gemcitabine with concurrent radical radiotherapy in locally advanced pancreatic cancer: interim resultshttps://api.elsevier.com/content/article/PII:S1359634905810742?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634905810742?httpAccept=text/plain
Annals of Oncology10.1093/annonc/mdx261.210201728iii76Gemcitabine plus capecitabine in elderly patients with advanced pancreatic cancerVasiliki Michalaki, Andreas Poydorou, Antonios Vezakis, Georgios Frangulidis, Theodosios Theodosopoulos, Christos Papadimitriouhttps://api.elsevier.com/content/article/PII:S0923753419659910?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419659910?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/28/suppl_3/mdx261.210/18107682/mdx261.210.pdf